Long-term safety and clinical outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic cervical spinal cord injury.
Overview
- Department of Neurological Surgery, University of California, San Diego, La Jolla, CA 92037, USA
- Department of Neurological Surgery, Orlando Health, Orlando, FL 32806, USA
- Department of Medicine, Division of Regenerative Medicine and CIRM Alpha Stem Cell Clinic, University of California, San Diego, La Jolla, CA 92037, USA
- Department of Anesthesiology, University of California, San Diego, La Jolla, CA 92037, USA
Abstract
Neural stem cell transplantation offers a promising avenue for spinal cord injury (SCI) repair, but demonstrating safety and feasibility in human populations remains a critical step. In this phase 1 trial, we investigate the long-term outcomes of cervical spinal cord implantation of NSI-566, a human spinal cord-derived neural stem cell line. With prospective data collection over 60 months, we assess adverse events, functional outcomes, and neurophysiological measures in a small cohort (N = 3) of chronic AIS-A SCI patients. We report a favorable safety profile with no evidence of tumorigenicity or procedure-related complications. Subclinical neurophysiological changes and limited functional gains were observed, although interpretation is constrained by the absence of a control group and the confounding effects of post-operative rehabilitation. These findings support the feasibility of intraparenchymal stem cell delivery for chronic SCI and underscore the need for larger, controlled trials to clarify efficacy and optimize therapeutic parameters.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Data and code availability
No new custom code was generated in this study; however, the scripts used for data analysis are available from the corresponding author upon reasonable request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 6 keywords, 13 MeSH terms, 2 funders, 40 references.
Cite
This paper
Abraham, M. E., Martin, J. R., Seaton, M., Brandel, M. G., Forseth, K. J., Jamieson, C., Marsala, M., & Ciacci, J. D. (2026). Long-term safety and clinical outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic cervical spinal cord injury. Stem cell reports, 21(6), 102926. https://
BibTeX
@article{abraham2026long
author = {Abraham, Mickey E and Martin, Joel R and Seaton, Margaret and Brandel, Michael G and Forseth, Kiefer J and Jamieson, Catriona and Marsala, Martin and Ciacci, Joseph D},
title = {{Long-term safety and clinical outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic cervical spinal cord injury}},
journal = {Stem cell reports},
year = {2026},
month = may,
volume = {21},
number = {6},
pages = {102926},
publisher = {Elsevier},
issn = {2213-6711},
doi = {10.1016/
url = {https://
pmid = {42167221},
pmcid = {PMC13261865}
}
RIS
TY - JOUR
AU - Abraham, Mickey E
AU - Martin, Joel R
AU - Seaton, Margaret
AU - Brandel, Michael G
AU - Forseth, Kiefer J
AU - Jamieson, Catriona
AU - Marsala, Martin
AU - Ciacci, Joseph D
TI - Long-term safety and clinical outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic cervical spinal cord injury
T2 - Stem cell reports
J2 - Stem Cell Reports
PY - 2026
DA - 2026/
VL - 21
IS - 6
SP - 102926
SN - 2213-6711
PB - Elsevier
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "Long-term safety and clinical outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic cervical spinal cord injury",
"container-title": "Stem cell reports",
"author": [
{
"family": "Abraham",
"given": "Mickey E"
},
{
"family": "Martin",
"given": "Joel R"
},
{
"family": "Seaton",
"given": "Margaret"
},
{
"family": "Brandel",
"given": "Michael G"
},
{
"family": "Forseth",
"given": "Kiefer J"
},
{
"family": "Jamieson",
"given": "Catriona"
},
{
"family": "Marsala",
"given": "Martin"
},
{
"family": "Ciacci",
"given": "Joseph D"
}
],
"container-title-short":
"volume": "21",
"issue": "6",
"page": "102926",
"DOI": "10.1016/
"PMID": "42167221",
"PMCID": "PMC13261865",
"ISSN": "2213-6711",
"publisher": "Elsevier",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
21
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.xcrm.2024.101841
- Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury.Journal: Cell reports. MedicineIn common: other condition, 7 references
- [2] doi:10.1007/s10571-023-01344-6
- The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review.Journal: Cellular and molecular neurobiologyIn common: other condition, 3 references
- [3] doi:10.1038/s41467-022-33611-3 [code]
- Generalizable spelling using a speech neuroprosthesis in an individual with severe limb and vocal paralysis.Journal: Nature communicationsIn common: author Margaret Seaton
- [4] doi:10.1038/s41598-025-90489-z
- Bioinformatics analysis reveals key mechanisms of oligodendrocytes and oligodendrocyte precursor cells regulation in spinal cord Injury.Journal: Scientific reportsIn common: other condition, 3 references
- [5] doi:10.1016/j.redox.2024.103469
- Macropinocytosis enhances foamy macrophage formation and cholesterol crystallization to activate NLRP3 inflammasome after spinal cord injury.Journal: Redox biologyIn common: other condition, 3 references
- [6] doi:10.1038/s41392-022-01134-4
- Stem cell-based therapy for human diseases.Journal: Signal transduction and targeted therapyIn common: 2 references
- [7] doi:10.1038/s41467-026-71162-z
- A controllable human spinal cord model with full dorsoventral patterning.Journal: Nature communicationsIn common: 2 references
- [8] doi:10.1186/s13018-025-06500-w
- MiR499-5P loaded MSC derived exosomes affect oxidative stress and inflammatory response after spinal cord injury by targeting genes.Journal: Journal of orthopaedic surgery and researchIn common: other condition, 2 references
- [9] doi:10.1177/21925682251383489
- Intervention of Rutin and Ochnaflavone in the Attenuation of Neuroinflammation and Neuronal Apoptosis in Spinal Cord Injury.Journal: Global spine journalIn common: other condition, 2 references
- [10] doi:10.1016/j.bioactmat.2023.11.013
- Local delivery of EGFR<sup>+</
sup>NSCs-derived exosomes promotes neural regeneration post spinal cord injury via miR-34a-5p/ HDAC6 pathway. Journal: Bioactive materialsIn common: other condition, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
